• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol. Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complicatio

Giuseppe

Emeritus
Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications. (J Virol., abstract, edited)

6. J Virol. 2010 Feb 3. [Epub ahead of print]

Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications.

Huber VC, Peltola V, McCullers JA. - Department of Infectious Disease, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN, 38105; Department of Pediatrics, Turku University Hospital, 20521 Turku, Finland.

Secondary bacterial infections contribute to morbidity and mortality from influenza. Vaccine effectiveness is typically assessed using prevention of influenza as an endpoint, not secondary infections. We vaccinated mice with formalin-inactivated influenza vaccine preparations containing disparate HA and NA proteins, and demonstrated an ability to induce the appropriate anti-HA and anti-NA immune profiles. Protection from both primary viral and secondary bacterial infection was demonstrated with vaccine-induced immunity directed toward either the HA or the NA. This finding suggests that immunity toward the NA component of the virion is desirable and should be considered in generation of influenza vaccines.

PMID: 20130054 [PubMed - as supplied by publisher]
-
-----
 
Back
Top Bottom